Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Acta Oncologica (Stockholm, Sweden)|August 12, 2004
Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancerMarianne Nordsmark, Jens OvergaardActa Oncologica (Stockholm, Sweden)|July 31, 2015
Dosimetric evaluation of anatomical changes during treatment to identify criteria for adaptive radiotherapy in oesophageal cancer patientsTine Bisballe Nyeng, Marianne Nordsmark, Lone HoffmannActa Oncologica (Stockholm, Sweden)|August 21, 2013
Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancerMette Winther, Jan Alsner, Trine Tramm, et al.Acta Oncologica (Stockholm, Sweden)|September 14, 2010
Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patientsMarianne Marquard Knap, Lone Hoffmann, Marianne Nordsmark, et al.Acta Oncologica (Stockholm, Sweden)|October 21, 2015
Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancerMette Winther, Jan Alsner, Trine Tramm, et al.JACC. Cardiooncology|January 6, 2022
Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative IntentMette Marie A Søndergaard, Marianne Nordsmark, Kirsten M Nielsen, et al.The Lancet. Oncology|October 4, 2005
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trialJens Overgaard, Jesper Grau Eriksen, Marianne Nordsmark, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Increased intratumoral FOXP3-positive regulatory immune cells during interleukin-2 treatment in metastatic renal cell carcinomaHanne Krogh Jensen, Frede Donskov, Marianne Nordsmark, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2007
Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patientsMarianne Nordsmark, Jesper Grau Eriksen, Val Gebski, et al.Acta Oncologica (Stockholm, Sweden)|October 15, 2025
Real-world outcomes after concurrent chemo-radiotherapy in patients with locally advanced esophageal and gastroesophageal junction cancerHanna Rahbek Mortensen, Lone Hoffmann, Marianne Nordsmark, et al.Pageof 7